← back to search

Ken Furudate

The University of Texas MD Anderson Cancer Center · JP
Area of research
Hematology · Cancer Research
Research interest
Research interests include Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Chronic Myeloid Leukemia Treatments.
h-index
16
citations
1,452
works
90
NIH funding
—
primary concept
Medicine
email
furudate@hirosaki-u.ac.jp

Recent publications

Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasms
Blood 2022cited by 137position: middledoi
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
Nature Communications 2020cited by 377position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Vanessa A. Quevedo Barrios · Brigham and Women's Hospital1 papers (2022–2022)Feng Wang · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Courtney D. DiNardo · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Linda Zhang · Baylor College of Medicine1 papers (2022–2022)Tapan M. Kadia · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Veronica Guerra · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Yuanqing Yan · Northwestern University1 papers (2022–2022)Koichi Takahashi · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Andrew Nguyen · University of North Carolina at Chapel Hill1 papers (2022–2022)Rashmi Kanagal‐Shamanna · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Guillermo Garcia‐Manero · Cancer Clinic1 papers (2022–2022)P. Andrew Futreal · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Joanne I. Hsu · Harvard University1 papers (2022–2022)Naval Daver · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Benjamin L. Ebert · Harvard University1 papers (2022–2022)Adam S. Sperling · Harvard University1 papers (2022–2022)Marie McConkey · Dana-Farber Cancer Institute1 papers (2022–2022)Curtis Gumbs · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Peter G. Miller · Brigham and Women's Hospital1 papers (2022–2022)Hagop M. Kantarjian · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)